<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>103(1)</volume><submitter>Schlenk RF</submitter><journal>Haematologica</journal><pagination>e25-e28</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5777210</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials.</pubmed_title><pmcid>PMC5777210</pmcid><pubmed_authors>Kreuzer KA</pubmed_authors><pubmed_authors>Noens L</pubmed_authors><pubmed_authors>Spencer A</pubmed_authors><pubmed_authors>Candoni A</pubmed_authors><pubmed_authors>Berkowitz N</pubmed_authors><pubmed_authors>Raffoux E</pubmed_authors><pubmed_authors>Vusirikala M</pubmed_authors><pubmed_authors>Pabst T</pubmed_authors><pubmed_authors>Ottmann O</pubmed_authors><pubmed_authors>Krauter J</pubmed_authors><pubmed_authors>Bouscary D</pubmed_authors><pubmed_authors>Schaich M</pubmed_authors><pubmed_authors>Weber HJ</pubmed_authors><pubmed_authors>Schlenk RF</pubmed_authors><pubmed_authors>Gil JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials.</name><description/><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jan</publication><modification>2025-04-04T07:16:25.994Z</modification><creation>2025-04-04T07:16:25.994Z</creation></dates><accession>S-EPMC5777210</accession><cross_references><pubmed>29051280</pubmed><doi>10.3324/haematol.2017.172411</doi></cross_references></HashMap>